Key result
Myocarditis following COVID-19 vaccination shows lower severity and fewer complications than post-infection myocarditis.
Why the study?
Does COVID-19 vaccination compared to COVID-19 infection result in less severe myocarditis and better prognosis in patients developing new-onset heart failure?
Observational (n=146)
No
Does COVID-19 vaccination compared to COVID-19 infection result in less severe myocarditis and better prognosis in patients developing new-onset heart failure?
Myocarditis following COVID-19 vaccination is associated with less severe cardiac complications and a better prognosis compared to myocarditis following COVID-19 infection.
Answers are grounded in this paper and cite their sources.
Should not deter COVID-19 vaccination uptake; supports prioritization of immunization over infection risks.
INTRODUCTION: Myocarditis is a rare but significant cardiovascular complication that may occur after receiving COVID-19 vaccines, particularly in younger individuals. The majority of cases have been reported after receiving mRNA-based vaccines, while inactivated and viral vector-based vaccines have been associated with fewer occurrences. Despite this, myocarditis is much more common and results in a poorer prognosis following COVID-19 infection. However, the relationship between myocarditis post-vaccination and its potential mechanisms remains unclear due to limited information. METHODS: This study investigated patients with myocarditis (new-onset heart failure) who had received the COVID-19 vaccine and those who had been infected with COVID-19 between March 2021 and March 2023 in Farshchian Cardiovascular Hospital in Hamedan. The data was analyzed using Stata version 14 software and Python. RESULTS: Among 146 myocarditis patients, unvaccinated individuals had higher rates of hypertension, diabetes, obstructive pulmonary disease, and substance abuse, and exhibited more severe cardiac issues like mitral regurgitation and ventricular dysfunction. Vaccinated patients had better lab results and fewer severe symptoms. A model identified advanced age and cardiovascular dysfunction as key mortality risks, suggesting vaccination may mitigate severe cardiac complications and improve outcomes. CONCLUSION: The findings of this study show that although there is a risk of myocarditis as a side effect following the COVID-19 vaccination, its severity is far less than the occurrence following the COVID-19 infection, with fewer complications and a better prognosis. However, more studies are still necessary to complete the existing findings and clarify their unknown aspects.
No takes yet. Share an insight, caveat, or question.
Karimi et al. (2026) conducted an observational in Myocarditis (new-onset heart failure) (n=146). COVID-19 vaccination vs. Unvaccinated individuals (COVID-19 infection) was evaluated. Among 146 patients with myocarditis, COVID-19 vaccination was associated with less severe cardiac complications and a better prognosis compared to unvaccinated patients with COVID-19 infection.
Synapse has enriched 10 related papers. Consider them for comparative context: